Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (691-700 of 819) with videos related to

Pageof 82
Sort By:
Annals of Surgery|August 11, 2015
Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patientsLinwah Yip, Marina N Nikiforova, Jenny Y Yoo, et al.
Translational Vision Science & Technology|December 30, 2021
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography InstrumentsJennifer K Sun, Kristin Josic, Michele Melia, et al.
Journal for Immunotherapy of Cancer|June 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapyRyan J Sullivan, Anthony R Cillo, Robert L Ferris, et al.
Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2009
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancerLisheng Ge, Dejan Baskic, Per Basse, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2019
GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid GlandMarina N Nikiforova, Alyaksandr V Nikitski, Federica Panebianco, et al.
Clinical and Translational Radiation Oncology|March 26, 2026
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)Kasey R Cargill, Phillip M Pifer, John A Vargo, et al.
Cancer|September 2, 2011
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinomaLeo A Niemeier, Haruko Kuffner Akatsu, Chi Song, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancersNikhil Gupta, Anil K Dasyam, Sally E Carty, et al.
Pageof 82

Showing results (691-700 of 819) with videos related to

Sort By:
Pageof 82
Annals of Surgery|August 11, 2015
Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patientsLinwah Yip, Marina N Nikiforova, Jenny Y Yoo, et al.
Translational Vision Science & Technology|December 30, 2021
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography InstrumentsJennifer K Sun, Kristin Josic, Michele Melia, et al.
Journal for Immunotherapy of Cancer|June 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapyRyan J Sullivan, Anthony R Cillo, Robert L Ferris, et al.
Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.
JAMA Ophthalmology|July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical TrialJeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2009
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancerLisheng Ge, Dejan Baskic, Per Basse, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2019
GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid GlandMarina N Nikiforova, Alyaksandr V Nikitski, Federica Panebianco, et al.
Clinical and Translational Radiation Oncology|March 26, 2026
Outcomes of patients with oral cavity squamous cell carcinomas with perineural invasion treated with adjuvant intensity modulated radiation therapy (IMRT)Kasey R Cargill, Phillip M Pifer, John A Vargo, et al.
Cancer|September 2, 2011
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinomaLeo A Niemeier, Haruko Kuffner Akatsu, Chi Song, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2013
RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancersNikhil Gupta, Anil K Dasyam, Sally E Carty, et al.
Pageof 82